Envisia Therapeutics

2 Decision Makers · 2 Verified Contacts

📍 Morrisville, North Carolina, United StatesBiotechnology🗓 Est. 2013👥 11–50 employees

About Envisia Therapeutics

Envisia Therapeutics is a biotechnology company focused on the research and development of novel ocular therapies.

Leadership & Decision Makers

Contact details of 2 Envisia Therapeutics decision makers

Frank J. Malinoski

CMO

Benjamin Yerxa

Founder

General Emails

General company emails, e.g. customer support lines

    info@envisiatherapeutics.com

    General Inquiries

Similar Companies like Envisia Therapeutics

Syneos Health

syneoshealth.com
Biotechnology · Morrisville, North Carolina, United States · Est. 1985 · 1001–5000 employees · $1B–$1000B

HQ: Morrisville, North Carolina, United States

Kite Pharma

kitepharma.com
Biotechnology · Los Angeles, CA · Est. 2009 · 101–250 employees

HQ: Los Angeles, CA

Adimab

adimab.com
Biotechnology · Lebanon, New Hampshire, United States · Est. 2007 · 101–250 employees

HQ: Lebanon, New Hampshire, United States

Loxo Oncology

loxooncology.com
Pharmaceuticals · New York, NY · Est. 2013 · 501–1000 employees

HQ: New York, NY

Seagen

seagen.com
Biotechnology · Bothell, Washington, United States · Est. 1998 · 1001–5000 employees · $500M–$1B

HQ: Bothell, Washington, United States

Explore similar firms in the Biotechnology sector

Company Info

(919)973-1440

Morrisville, North Carolina, United States

Specialization: Therapeutics,
Legal Name: Envisia Therapeutics, Inc.
Business Type: Private
Employees: 11-50
Rounds: Series A
Founded Date: 2013
Company Type: For Profit
Operating Status: Active
Last Funding Type: Series A
Phone Number: (919)973-1440
Last Investment Activity: Feb 3, 2017
Investments Activity: Feb 3, 2017 Mar 17, 2016 Oct 19, 2015

Our service is undergoing beta testing, and you can get all the information that is closed on this page for free by registering. You will not need to provide your credit/debit card details.